key: cord-1029556-cmyzotg1
authors: Fusco, Roberta; Grassi, Roberta; Granata, Vincenza; Setola, Sergio Venanzio; Grassi, Francesca; Cozzi, Diletta; Pecori, Biagio; Izzo, Francesco; Petrillo, Antonella
title: Artificial Intelligence and COVID-19 Using Chest CT Scan and Chest X-ray Images: Machine Learning and Deep Learning Approaches for Diagnosis and Treatment
date: 2021-09-30
journal: J Pers Med
DOI: 10.3390/jpm11100993
sha: 9713cdbf93a14114218908e33fd96a5928a61d3b
doc_id: 1029556
cord_uid: cmyzotg1

Objective: To report an overview and update on Artificial Intelligence (AI) and COVID-19 using chest Computed Tomography (CT) scan and chest X-ray images (CXR). Machine Learning and Deep Learning Approaches for Diagnosis and Treatment were identified. Methods: Several electronic datasets were analyzed. The search covered the years from January 2019 to June 2021. The inclusion criteria were studied evaluating the use of AI methods in COVID-19 disease reporting performance results in terms of accuracy or precision or area under Receiver Operating Characteristic (ROC) curve (AUC). Results: Twenty-two studies met the inclusion criteria: 13 papers were based on AI in CXR and 10 based on AI in CT. The summarized mean value of the accuracy and precision of CXR in COVID-19 disease were 93.7% ± 10.0% of standard deviation (range 68.4–99.9%) and 95.7% ± 7.1% of standard deviation (range 83.0–100.0%), respectively. The summarized mean value of the accuracy and specificity of CT in COVID-19 disease were 89.1% ± 7.3% of standard deviation (range 78.0–99.9%) and 94.5 ± 6.4% of standard deviation (range 86.0–100.0%), respectively. No statistically significant difference in summarized accuracy mean value between CXR and CT was observed using the Chi square test (p value > 0.05). Conclusions: Summarized accuracy of the selected papers is high but there was an important variability; however, less in CT studies compared to CXR studies. Nonetheless, AI approaches could be used in the identification of disease clusters, monitoring of cases, prediction of the future outbreaks, mortality risk, COVID-19 diagnosis, and disease management.

In December 2019, a large outbreak of a novel coronavirus infection occurred in Wuhan, Hubei Province, China. The novel coronavirus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses and led to a dramatic pneumonia outbreak in China [1] [2] [3] . The disease caused by the virus, named coronavirus disease by the World Health Organization (WHO), can be spread through human-to-human contact. On January 30, 2020, the WHO declared a global public health emergency against the outbreak of COVID-19 [4] [5] [6] .

The COVID-19 diagnosis is confirmed by the positive results of the nucleic acid amplification test of the respiratory tract or blood specimens using reverse transcription real-time fluorescence polymerase chain reaction (RT-PCR) [7, 8] . However, methods like chest X-ray (CXR) and chest Computed Tomography (CT) scan are medical imaging techniques, which are widely used to assess the pneumonia due to COVID-19 [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . The reported sensitivity of CXR for COVID-19 pneumonia is relatively low in the early phase of the disease and in mild cases (69%). Conversely, CT shows greater sensitivity for early pneumonic change, disease progression, and alternative diagnosis; the administration of the intravenous contrast medium, is essential for the diagnosis of pulmonary thromboembolism [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . Despite recent advances in diagnostic tools, radiologic imaging alone is not sufficient for the COVID-19 pneumonia diagnosis. Imaging should be associated to clinical and laboratory testing. In addition, the American College of Radiology, so as the Italian Society of Radiology (SIRM) does not recommend chest CT as a screening tool, suggesting this method only for symptomatic patients with specific clinical indications. Bilateral distribution of ground glass opacities (GGO) with or without consolidation in posterior and peripheral lungs was the cardinal hallmark of COVID-19 disease [6, 22] . Among COVID-19 patients, it is reasonable to assume that those with a very severe disease could exhibit high risk of venous thromboembolism, including deep vein thrombosis and/or pulmonary embolism. In this scenario, it is opened the question on the use of contrast medium during CT studies [20] [21] [22] .

The mathematical models for COVID-19 pandemic, confirmed by practical evidence in China, in Italy, and in the rest of the world, have shown that the rapid substantial increase in the number of critically ill patients exceeds in the total capacity of Intensive care units (ICUs), even excluding routine critical admissions for trauma, stroke, and other emergencies.

In the context of the COVID-19 outbreak, there is a painstaking need for ready-touse resources for data acquisition and artificial intelligence (AI) algorithms to accelerate the search for effective and safe treatments. The progressive integration of radiomics approaches and AI-based solutions in healthcare is already changing established paradigms in the entire healthcare ecosystem, leveraging the progressive digitalization of medical data [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] . Specifically, diagnostic and decision support systems developed for medical imaging are the first successful examples of innovation for health. AI-based methods have led to diagnostic applications that accelerate image acquisition, preprocessing, annotation and interpretation, offering an "augmentation" of the radiologists, rather than their unrealistic substitution. In particular, the application of AI in medical imaging has improved the assessment, diagnosis and early detection of neurodegenerative diseases, heart diseases, with a specifically high impact on breast and lung cancer [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] .

Deep learning (DL) and machine learning (ML) are branches of AI that focus on producing systems that can learn from examples and improve without being explicitly programmed. ML is the study of computer algorithms that can improve automatically through experience and using data. Machine learning algorithms build a model based on sample data, known as "training data", to make predictions or decisions without being explicitly programmed to do so. Machine learning algorithms are used in a wide variety of applications, such as in medicine, email filtering, speech recognition, and computer vision, where it is difficult or unfeasible to develop conventional algorithms to perform the needed tasks. A subset of machine learning is closely related to computational statistics, which focus on making predictions using computers; but not all machine learning is statistical learning. The study of mathematical optimization delivers methods, theory and application domains to the field of machine learning. Data mining is a related field of study, focusing on exploratory data analysis through unsupervised learning.

Deep learning is a class of machine learning algorithms that uses multiple layers to progressively extract higher-level features from the raw input. For example, in image processing, lower layers may identify edges, while higher layers may identify the concepts relevant to a human such as digits or letters or faces. Deep-learning architectures such as deep neural networks, deep belief networks, deep reinforcement learning, recurrent neural networks and convolutional neural networks have been applied to fields including computer vision, speech recognition, natural language processing, machine translation, bioinformatics, drug design, medical image analysis, material inspection and board game programs, where they have produced results comparable to and in some cases surpassing human expert performance. DL and ML have been applied successfully in many fields, including health care and medical informatics. One important research direction leverages DL and ML to understand and fight COVID-19. Numerous lines of research have been initiated for the application and development of COVID-19-related DL and ML algorithms.

Several review articles have been published on the use of artificial intelligence approaches in COVID-19 research. Agbehadji et al. [54] , summarized how big data and AI models can be used for case detection and contact tracing of COVID-19. Bullock et al. [55] , discussed how AI is used to evaluate the challenges of COVID-19 at different scales, including molecular, medical, and epidemiological applications. Naud e [56] highlighted the actual and potential applications of AI in fighting COVID-19. Wu et al. [57] , surveyed the application of big data technology for preventing and managing COVID-19 in China.

Alballa et al. [58] , review the recent ML algorithms in this field and focus on their potential in two main applications: diagnosis of COVID-19 and prediction of mortality risk and severity, using simple clinical and laboratory data; they analyze the main features that were found to be the most relevant to these applications.

Our aim is to report an overview and update on AI-based methods application in COVID-19 disease using radiological images including CXR and CT focus on their potential in two main applications: diagnosis of COVID-19 and prediction of mortality risk and severity.

This narrative review is the result of an autonomous study without protocol and a registration number.

Several electronic datasets were searched: PubMed (US National Library of Medicine, http://www.ncbi.nlm.nih.gov/pubmed accessed on 24 June 2021), Scopus (Elsevier, http: //www.scopus.com/ accessed on 24 June 2021), Web of Science (Thomson Reuters, http:// apps.webof knowledge.com/ accessed on 24 June 2021) and Google Scholar (https://scholar.google.it/ accessed on 24 June 2021). The following search criteria have been used: "COVID-19" and "X-ray" and "ARTIFICIAL INTELLIGENCE"; "COVID-19" and "CT" and "ARTIFICIAL INTELLIGENCE"; "COVID-19" and "X-ray" and "DEEP LEARNING"; "COVID-19" and "CT" and "DEEP LEARNING"; "COVID-19" and "X-ray" and "MACHINE LEARNING"; "COVID-19" and "CT" and "MACHINE LEARNING".

The search covered the years from January 2019 to June 2021. The reference lists of the found papers were analyzed for papers not indexed in the electronic databases. All titles and abstracts were analyzed. The inclusion criteria were studied evaluating the use of AI methods in COVID-19 disease reporting performance results in terms of accuracy or precision or area under Receiver Operating Characteristic (ROC) curve (AUC). Articles published in the English language were included. Exclusion criteria were different topics, unavailability of full text, and not sufficient data.

The summarized accuracy, precision or specificity were calculated in terms of mean, standard deviation value and range. The Chi square test was used to assess differences statistically significant between CXR and CT results. p value < 0.05 was considered significant for all tests.

We identified 84 potentially relevant references through electronic searches. We identified 15 references through scanning reference lists of the identified paper that we added to the 84 references previously selected (total number of articles was 99). We then excluded 51 clearly irrelevant articles through screening titles and reading abstracts. We excluded 25 articles for the reasons listed in the exclusion criteria. A total of 23 article met the inclusion criteria. A diagram of included and excluded studies was summarized in the study flow diagram (Figure 1 ). Table 1 reports the classification problem, the classification approach and the performance results of the selected papers.

Thirteen papers using CXR and AI approaches in the COVID-19 disease were identified. The summarized mean value of the accuracy and precision of CRX in COVID-19 disease were 93.7% ± 10.0% of standard deviation (range 68.4-99.9%) and 95.7% ± 7.1% of standard deviation (range 83.0-100.0%), respectively.

Ten papers using chest CT and AI approaches in the COVID-19 disease were found. The summarized mean value of the accuracy and specificity of CT in COVID-19 disease were 89.1% ± 7.3% of standard deviation (range 78.0-99.9%) and 94.5% ± 6.4% of standard deviation (range 86.0-100.0%), respectively.

No statistically significant difference in summarized accuracy mean value between CXR and CT was observed using the Chi square test (p value > 0.05). CT CT There were 406 clearer COVID-19-positive lung CT images. The marked areas in the mask images are 0-"ground glass opacity," 1-"consolidations," 2-"lungs other," 3-"background. 

Artificial intelligence approaches have been used to predict the outbreak, to diagnose the disease, to analyze CXR and CT scan images, and more recently to predict mortality or progression risk to severe respiratory failure. This evidence clearly indicates the need for the most rapid and accurate diagnostic and stratification of patients with COVID-19, with technologies and expertise easily accessible from all nodes of the healthcare system with responsibility of diagnosis of COVID-19 and management of patients (either in the health structures or at home) [59] .

Chest radiographs are first-line investigations in many countries. Researchers could examine not only the initial imaging findings and extent of respiratory involvement, but also how radiographic progression in serial studies correlates with patients' clinical outcome [60] [61] [62] 66] . CT examination has been used extensively worldwide to evaluate the grade and the extension of the viral pneumonia by COVID-19 and in the followup, which are also based on AI algorithms [67] [68] [69] [70] . Several radiological organizations do not recommend CT as primary diagnostic/screening tool for COVID-19 [71] [72] [73] [74] or have excluded CT findings from its diagnostic criteria [75] . Radiologists focus on main CT findings (GGO, consolidation, reticulation/thickened interlobular septa, nodules), and lesion distribution (left, right or bilateral lungs) [76] [77] [78] [79] [80] .

AI methods seek to exploit mainly for characterizing COVID-19 pneumonia CT patterns, for monitoring patients in clinical settings and for estimating efficacy of treatment. Based on the data derived from clinical parameters, AI may provide critical data for resource allocation and decision-making by prioritizing the need of ventilators and respiratory supports in the Intensive Care Unit [81] [82] [83] . AI was used for the COVID-19 disease detection and quantification from CXR and CT images [63, [81] [82] [83] [84] [85] [86] [87] [88] . AI can also be used for predicting the chances of recovery or mortality in COVID-19 and to provide daily updates, storage and trend analysis and charting the course of treatment.

CT scan-based and CXR-based identification and detection of COVID-19 have been implemented using pretrained networks such as InceptionV3, VGGNet, InceptionResNetV2, ResNet, etc., and achieved benchmark accuracies as high as 99% [84] .

At the same time, radiomics approaches can be usefully implemented, focusing on segmentation techniques of the lung parenchyma based on region growing techniques and on other radiomics COVID-19 specific features and their use with machine learning such as Support Vector Machines (SVMs) or Random Forests [86] [87] [88] .

In the study of Sethy et al. [83] , the deep learning methodology is reported for detection of a coronavirus infected patient by CXR. The suggested classification model, Resnet50 plus Support Vector Machine (SVM), achieved accuracy and false positive rate of 95.38% and 95.52% respectively for detecting COVID-19.

Jiao et al. [89] , using the CXR as input to an EfficientNet deep neural network combined with clinical data, assessed the ability to predict COVID-19 disease severity (critical or noncritical). They reported that when CXR was added to clinical data for severity prediction, the area under the receiver operating characteristic curve (ROC-AUC) increased from 0.821 to 0.846 on internal testing and from 0.731 to 0.792 on external testing; when deep-learning features were added to clinical data for progression prediction, the concordance index (C-index) increased from 0.769 to 0.805 on internal testing and from 0.707 to 0.752 on external testing; when image and clinical data were combined C-index increase from 0.805 to 0.781 on internal testing and from 0.752 to 0.715 on and internal testing.

Al-Waisy et al. [90] , proposed COVID-CheXNet system that is made by combining the results generated from two different deep learning models (e.g., ResNet34 and HRNet) on CXR: two predicted probability scores are computed, and the highest probability score is used to assign the input image to one of two classes for detecting COVID-19. The proposed COVID-CheXNet system reached to diagnose the COVID-19 patients with a detection accuracy rate of 99.99%, a sensitivity of 99.98%, a specificity of 100% and a precision of 100%. Cases used in this study come from different databases: 200 X-ray images with confirmed COVID-19 infections come by Cohen's GitHub database [91] ; 200 COVID-19 CXRs gathered from three different repositories: Radiopaedia dataset [92] , Italian Society of Medical and Interventional Radiology (SIRM) [93] and Radiological Society of North America (RSNA) [94]; 400 normal CXR by Kaggle's CXR dataset [95] .

Ozcan et al. [96] , proposed single layer-based (SLB) and feature fusion based (FFB) composite systems to detect COVID-19 in X-ray images using deep features. Four types of SLB (including AlexNet-fc6 (SLB1), ResNet18-pool5 (SLB2), ResNet18-fc1000 (SLB3), and ResNet50-fc1000 (SLB4)) and six types of FFB (including fc6-pool5 (FFB1), fc6-fc1000 (FFB2), fc6-fc1000 (FFB3), pool5-fc1000 (FFB4), pool5-fc1000 (FFB5), fc1000-fc1000 (FFB6)) were used in the study. The proposed FFB3 model reached the best average recognition rate of 87.64% in COVID-19, no-finding, and pneumonia classifications while reached as the best average recognition rate of 99.52% in COVID-19 and no-finding classifications.

Ozturc at al. [97] proposed a model for automatic COVID-19 detection using raw CXR images in order to perform the binary classification COVID-19 versus no findings and multiclass classification COVID-19 versus no findings. Their model produced a classification accuracy of 98.08% for binary classes and 87.02% for multi-class cases. The DarkNet model was used in the study as a classifier implementing 17 convolutional layers and introducing different filtering on each layer.

Du et al. [98] , applied machine learning (ML) to the task of detection of SARS-CoV-2 infection using basic laboratory markers. Moreover, they tested ML accuracy adding at laboratory markers the radiologist interpretations of chest radiographs. When they used the combination of laboratory markers and radiologist interpretations, the sensitivity of ML was over 90% while keeping moderate specificity.

Dey et al. [99] , proposed a classifier ensemble technique, utilizing Choquet fuzzy integral. It classifies CXR images in common pneumonia, confirmed COVID-19, and healthy lungs. They utilized the pre-trained convolutional neural network models to extract features and classify the CXR images using two dense layers and one softmax layer. The proposed method provides 99.00%, 99.00%, 99.00%, and 99.02% average recall, precision, F-score, and accuracy, respectively.

Alruwaili et al. [100] , proposed an enhanced Inception-ResNetV2 deep learning model that can diagnose chest X-ray scans with high accuracy of 99.83%. Besides, a Grad-CAM algorithm is used to enhance the visualization of the infected regions of the lungs in CXR images.

Bukhari et al. [101] , employed ResNet50 for COVID-19 detection using CXR images. They tried to differentiate four types of classes, which are healthy normal, bacterial pneumonia, viral pneumonia, and COVID-19 cases. They achieved an average accuracy of 98.18% and a F1-score of 98.19%.

Khan et al. [102] , proposed a model named CoroNet to identify COVID-19 in x-ray and CT scans utilizing a pretrained Xception convolution network. For the four classes (viral pneumonia, COVID-19, bacterial pneumonia, and normal), the first experiment attained an accuracy of 89.6%, while for three classes (normal, COVID-19, and pneumonia) obtained a total accuracy of 95.0%.

A COVIDX-Net model to help radiologists in identifying and diagnosing COVID-19 in CXR images was developed by Hemdan et al. [103] . They compared seven performances of seven pretrained deep learning networks; they are the InceptionV3, MobileNetV2, VGG19, DenseNet201, Inception-ResNetV2, ResNetV2, and Xception model. Based on their experiments, the VGG19 model achieved the highest accuracy of 90%.

Sethy and Behera [83] , introduced a hybrid approach that utilizes deep learning for feature extraction and support vector machine (SVM) for detecting patients contaminated with COVID-19 by using CXR images. Using the pretrained 13 distinct Convolutional Neural Network models, the SVM provided the best results on the deep features of the ResNet50 model achieving accuracy of 95.38% for detecting COVID-19 (ignoring SARS, MERS and ARDS).

Ouchicha et al. [104] , proposed a model named CVDNet to diagnose the COVID-19 cases. This model employed local and global features of CXR by using two parallel layers with various kernel sizes reaching an average accuracy of 97.20% for detecting COVID-19 cases.

Gozes et al. [81] , used deep learning models to explore AI CT image analysis tools in the detection, quantification, and tracking of coronavirus. A total of 106 COVID-19 chest CT scans (50 labeled by a radiologist, and other 56 by RT-PCR test) and 99 normal ones were used to find potential COVID-19 thoracic CT features and to evaluate disease progression over time, generating a quantitative score. Utilizing the deep-learning image analysis system developed, they achieved classification results for COVID -19 versus Ko et al. [105] , investigated a simple 2D deep learning framework, and named the fasttrack COVID-19 classification network (FCONet), in order to diagnose COVID-19 pneumonia based on a single chest CT image. FCONet was developed by transfer learning using one of four state-of-the-art pretrained deep learning models (VGG16, ResNet-50, Inception-v3, or Xception) as a backbone. Among the four pretrained models of FCONet, ResNet-50 showed excellent diagnostic performance (sensitivity 99.58%, specificity 100.00%, and accuracy 99.87%) and outperformed the other three pretrained models in the testing data set. In the additional external testing data set using low-quality CT images, the detection accuracy of the ResNet-50 model was the highest (96.97%).

Nguyen et al. [106] , examined deep learning models in order to identify COVID-19-positive patients on 3D CT datasets from different countries. The models achieved accuracy/AUC values of 0.87/0.826 (dataset at UT Southwestern), 0.97/0.988 (dataset at China), and 0.86/0.873 (dataset at Iran).

Zhang et al. [64] , used artificial intelligence technology proposing a COVSeg-NET model that can segment GGO lesions in COVID-19 chest CT images. The COVSeg-NET model is based on the fully convolutional neural network model structure, which mainly includes convolutional layer, nonlinear unit activation function, maximum pooling layer, batch normalization layer, merge layer, flattening layer, sigmoid layer, and so forth. The results showed a sensitivity and specificity of the COVSeg-NET model of 0.447 and 0.996 respectively.

Song et al. [107] , developed a deep learning network, which is called DeepPneumonia, to diagnose COVID-19 cases analyzing CT scans. Their proposed system was built on the ResNet50 using transfer learning technology. It could localize the essential lesion characteristics, especially GGO. Their system achieved an average AUC of 0.99 and sensitivity score of 93%. Besides, it reached an average AUC of 0.95 and sensitivity of 96% for bacterial pneumonia-infected cases.

Wang et al. [65] , developed an artificial intelligence system in a time-to-event analysis framework to integrate chest CT and clinical data for risk prediction of future deterioration to critical illness in patients with COVID-19. The artificial intelligence system achieved a C-index of 0.80 for predicting individual COVID-19 patients as having critical illness, and successfully stratified the patients into high-risk and low-risk groups with distinct progression risks (p < 0.0001).

Xu et al. [108] , proposed a fully automated COVID-19 diagnosis based on a 3D deep learning network-using chest CT scans. Their proposed system consists of four basic stages, which are pre-processing, candidate region segmentation, classification for each candidate region, and overall infection probability. The experimental results of this study showed that the summarized accuracy rate was 86.7%.

In addition, if the summarized accuracy of the selected papers is high, there was an important variability. The accuracy and applicability of AI approaches in COVID-19 from CXR or chest CTs have questioned, based on concerns of the radiologists' association, and given the impact of selection bias reported in first published results. Moreover, the limitation of this methodology is that if the patient is in a critical situation and unable to attend for CXR or CT scanning.

The analyzed papers showed the great potential of AI in COVID-19 pandemic by helping complex decision-making. However, most of the analyzed papers were experimental, and the produced models have not been deployed in real-world clinical setting. Those reported are impeded by several limitations. The available data sets may suffer from selection bias. The prognosis studies mostly encompass inpatients, who are usually sicker, whereas the diagnosis studies typically involve patients who already exhibit symptoms fitting with COVID-19. More data are needed on asymptomatic individuals and those with mild symptoms, who might not visit the hospital. Moreover, most of the studies reviewed employed imbalanced data sets, that is, those where many records in the training data set represent the negative class, and the positive class is under-represented. Thus, the reported performance of various AI algorithms applied in this context may have been affected by polarization of the context: a pandemic scenario. A high accuracy value in such cases could be attributed to the ability of the model to accurately identify negative samples and erroneously exclude all the positive COVID-19 cases. More effort is required to handle imbalanced data sets prior to the application of AI to COVID-19. The predictive performance of the models might also differ when using representative data that incorporates the targeted population, which merits further investigation.

Moreover, although AI is a promising tool in precision medicine, many factors such as low signal-to-noise ratio and complex data integration have challenged its efficacy. Both CXR and CT showed a high accuracy to detect pneumonia by COVID-19 and to predict the disease evolution, but which CXR is the first examination in this context and thus more data is available, CT is more capable to investigate extension and critical issues of the disease. However, CT images represent a difficult classification task due to the relatively large number of variable objects, specifically the imaged areas outside the lungs that are irrelevant to the diagnosis of pneumonia. Notably, the assessed features of the CT images were from patients with severe lung lesions at later stages of disease development. A larger number of databases to associate this with the disease progress and all pathologic stages of COVID-19 are necessary to optimize the diagnostic system.

In conclusion, AI approaches could be used in the identification of disease clusters, monitoring of cases, prediction of the future outbreaks, mortality risk, diagnosis of COVID-19, disease management by resource allocation, facilitating training, record maintenance and pattern recognition for studying the disease trend. 

WHO. Summary of Probable SARS Cases with onset of Illness from 1

WHO. Naming the Coronavirus Disease (COVID-2019) and the Virus That Causes It

A doubt of multiple introduction of SARS-CoV-2 in Italy: A preliminary overview

COVID-19 Dashboard

European Centre for Disease Prevention and Control (ECDC) Public Health Emergency Team Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom

Diagnostic Accuracy Estimates for COVID-19 Real-Time Polymerase Chain Reaction and Lateral Flow Immunoassay Tests with Bayesian Latent-Class Models

Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst

The association between serum levels of micronutrients and the severity of disease in patients with COVID-19

Radiological management of COVID-19: Structure your diagnostic path to guarantee a safe path

Preparation of a radiology department in an Italian hospital dedicated to COVID-19 patients

Correction to: Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis

An approach to the classification of COVID-19 based on CT scans using convolutional features and genetic algorithms

Anterior mediastinal lesions: CT and MRI features and differential diagnosis

Comparing different planimetric methods on volumetric estimations by using cone beam computed tomography

Cross-Site Severity Assessment of COVID-19 from CT Images via Domain Adaptation

Chest CT for early detection and management of coronavirus disease (COVID-19): A report of 314 patients admitted to Emergency Department with suspected pneumonia

Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab

Chest computed tomography in COVID-19 infection

Facing the COVID-19 emergency: We can and we do

Radiotherapy during COVID-19 pandemic. How to create a No fly zone: A Northern Italy experience

Proposal of a low-dose, long-pitch, dual-source chest CT protocol on third-generation dual-source CT using a tin filter for spectral shaping at 100 kVp for CoronaVirus Disease 2019 (COVID-19) patients: A feasibility study

COVID-19 outbreak in Italy: Experimental chest X-ray scoring system for quantifying and monitoring disease progression

It's not over until it's over: The chameleonic behavior of COVID-19 over a six-day period

Lymphadenopathy after BNT162b2 Covid-19 Vaccine: Preliminary Ultrasound Findings

Artificial intelligence to codify lung CT in Covid-19 patients

Use of CT and artificial intelligence in suspected or COVID-19 positive patients: Statement of the Italian Society of Medical and Interventional Radiology

Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: Key points for radiologists

The lingering manifestations of COVID-19 during and after convalescence: Update on long-term pulmonary consequences of coronavirus disease 2019 (COVID-19)

The lung ultrasound: Facts or artifacts? In the era of COVID-19 outbreak

COVID-19) infection: Findings and correlation with clinical outcome

Breast imaging and cancer diagnosis during the COVID-19 pandemic: Recommendations from the Italian College of Breast Radiologists by SIRM

Radiographic severity index in COVID-19 pneumonia: Relationship to age and sex in 783 Italian patients

Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: Association with clinical and laboratory data

Quantitative Chest CT analysis in discriminating COVID-19 from non-COVID-19 patients

COVID-19 pneumonia: Computer-aided quantification of healthy lung parenchyma, emphysema, ground glass and consolidation on chest computed tomography (CT)

Evolution of CT Findings and Lung Residue in Patients with COVID-19 Pneumonia: Quantitative Analysis of the Disease with a Computer Automatic Tool

Artificial intelligence: A challenge for third millennium radiologist

Artificial intelligence: Who is responsible for the diagnosis?

Artificial intelligence in cardiac radiology

Radiomics nomogram for predicting the malignant potential of gastrointestinal stromal tumours preoperatively

CT-based radiomics for preoperative prediction of early recurrent hepatocellular carcinoma: Technical reproducibility of acquisition and scanners

Dose reduction potential of vendor-agnostic deep learning model in comparison with deep learning-based image reconstruction algorithm on CT: A phantom study

Distinguishing benign and malignant lesions on contrast-enhanced breast cone-beam CT with deep learning neural architecture search

Axillary lymph node metastasis prediction by contrastenhanced computed tomography images for breast cancer patients based on deep learning

Role of Chest Imaging in Viral Lung Diseases

Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas

Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning

Coronary artery disease (CAD) extension-derived risk stratification for asymptomatic diabetic patients: Usefulness of low-dose coronary computed tomography angiography (CCTA) in detecting high-risk profile patients

Computed tomography-based radiomics model for discriminating the risk stratification of gastrointestinal stromal tumors

Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer

Coronavirus disease 2019 (COVID-19) in Italy: Features on chest computed tomography using a structured report system. Sci

COVID-19) in Italy: Double Reading of Chest CT Examination

Review of Big Data Analytics, Artificial Intelligence and Nature-Inspired Computing Models towards Accurate Detection of COVID-19 Pandemic Cases and Contact Tracing

Mapping the landscape of Artificial Intelligence applications against COVID-19

Artificial intelligence vs. covid-19: Limitations, constraints and pitfalls

Application of Big Data Technology for COVID-19 Prevention and Control in China: Lessons and Recommendations

Machine Learning Approaches in COVID-19 Diagnosis, Mortality, and Severity Risk Prediction: A Review

Home mobile radiography service in the COVID-19 era

Covid-19 infection in cancer patients: The management in a diagnostic unit

Chest Radiograph Findings in Asymptomatic and Minimally Symptomatic Quarantined Patients in Codogno, Italy during COVID-19 Pandemic

Classification of lung nodules based on CT images using squeezeand-excitation network and aggregated residual transformations

A deep learning algorithm using CT images to screen for Corona virus disease (COVID-19)

COVSeg-NET: A deep convolution neural network for COVID -19 lung CT image segmentation

Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data

Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic

COVID-19): Role of Chest CT in Diagnosis and Management

Clinical features of patients infected with 2019 novel coronavirus in

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology

Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

ACR Recommendations for the Use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection

The Royal Australian and New Zealand College of Radiologist. COVID-19 Updates

The Royal College of Radiologists. RCR position on the role of CT in patients suspected with COVID-19 infection

Canadian Society of Thoracic Radiology and Canadian Association of Radiologists' Statement on COVID -19

Radiology Department Preparedness for COVID-19: Radiology Scientific Expert Review Panel

COVID-19): A Perspective from China

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in

CT Manifestations of Two Cases of 2019 Novel Coronavirus (2019-nCoV) Pneumonia

Severe Acute Respiratory Disease in a Huanan Seafood Market Worker: Images of an Early Casualty

Rapid AI Development Cycle for the Coronavirus (COVID-19) Pandemic: Initial Results for Automated Detection & Patient Monitoring using Deep Learning CT Image Analysis

The role of artificial intelligence in management of critical COVID-19 patients

Detection of coronavirus Disease (COVID-19) based on Deep Features and Support Vector Machine

Automatic detection of coronavirus disease (COVID-19) in X-ray and CT images: A machine learning-based approach

Using Artificial Intelligence to Detect COVID-19 and Community-acquired Pneumonia Based on Pulmonary CT: Evaluation of the Diagnostic Accuracy

Comparing and combining algorithms for computer-aided detection of pulmonary nodules in computed tomography scans: The ANODE09 study

A CAD system for nodule detection in low-dose lung CTs based on region growing and a new active contour model

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

Prognostication of patients with COVID-19 using artificial intelligence based on chest X-rays and clinical data: A retrospective study

Hybrid deep learning framework for identifying COVID-19 virus in chest X-rays images. Soft Comput. 2020

COVID-19 Image Data Collection

The new lens dose limit: Implication for occupational radiation protection

Italian Society of Medical and Interventional Radiology (SIRM). 2020. Available online

Kaggle's Chest X-ray Images (Pneumonia) Dataset. 2020

A new composite approach for COVID-19 detection in X-ray images using deep features

Automated detection of COVID-19 cases using deep neural networks with X-ray images

Machine learning application for the prediction of SARS-CoV-2 infection using blood tests and chest radiograph

Choquet fuzzy integral-based classifier ensemble technique for COVID-19 detection

COVID-19 Diagnosis Using an Enhanced Inception-ResNetV2 Deep Learning Model in CXR Images

The Diagnostic Evaluation of Convolutional Neural Network (CNN) for the Assessment of Chest X-ray of Patients Infected with COVID-19; medRxiv

CoroNet: A deep neural network for detection and diagnosis of COVID-19 from chest x-ray images

COVIDx-Net: A Framework of Deep Learning Classifiers to Diagnose COVID-19 in X-ray Images

CVDNet: A novel deep learning architecture for detection of coronavirus (Covid-19) from chest x-ray images

COVID-19 Pneumonia Diagnosis Using a Simple 2D Deep Learning Framework With a Single Chest CT Image: Model Development and Validation

Deep Learning-Based COVID-19 Pneumonia Classification Using Chest CT Images: Model Generalizability. Front

Deep learning Enables Accurate Diagnosis of Novel Coronavirus (COVID-19) with CT images

The authors are grateful to Alessandra Trocino, librarian at the National Cancer Institute of Naples, Italy. Moreover, for their collaboration, authors are grateful to Andrea Esposito, Paola Gargiulo, Giuditta Giannotti, Paolo Pariante, Martina Totaro (research support) of Radiology Division, "Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli", Naples, I-80131, Italy.

The authors declare no conflict of interest.